Do patients care about accelerated approval drugs?
World of DTC Marketing
MARCH 23, 2022
85% of accelerated approvals from 2010 to 2020 were for oncology indications. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. of approvals), cancer (35.6%), and other rare diseases (24.7%). Since then, accelerated Approval has shifted focus to oncology drugs.
Let's personalize your content